Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: CellaVision AB

Market Cap 326.29Cr 34Cr 30Cr 28Cr 26Cr 48Cr 3.21TCr 49Cr 126.46Cr 1.58TCr 127.85Cr 125.11Cr 5.49TCr P/E 2026 *
22.5x
P/E 2027 * 18.7x
Enterprise Value 304.47Cr 32Cr 28Cr 26Cr 24Cr 45Cr 3TCr 45Cr 118Cr 1.48TCr 119.3Cr 116.74Cr 5.13TCr EV / Sales 2026 *
3.95x
EV / Sales 2027 * 3.48x
Free-Float
83.08%
Yield 2026 *
2.01%
Yield 2027 * 2.25%
1 day-3.12%
1 week-1.01%
Current month+13.43%
1 month+10.32%
3 months-5.00%
6 months-11.17%
Current year-12.98%
1 week 136.2
Extreme 136.2
154.4
1 month 118.4
Extreme 118.4
154.4
Current year 117.6
Extreme 117.6
166.8
1 year 117.6
Extreme 117.6
194
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
503.5
10 years 53.75
Extreme 53.75
503.5
Manager TitleAgeSince
Chief Executive Officer - 05/06/2026
Director of Finance/CFO 46 02/09/2025
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 04/05/2018
Chairman 64 29/04/2021
Date Insider Type Main position Quantity % Market Cap.
12/06Buy 760 0.0032%
09/06Buy

Director

314 0.0013%
09/06Buy

Founder

33,000 0.1384%
Change 5-day change 1-year change 3-year change Capi.($)
-3.12%-1.01%-24.84%-22.45% 34Cr
-1.89%-7.87%-0.47%-29.93% 1.56TCr
-2.00%-5.63%+32.66%+52.64% 156.98Cr
+0.19%+1.50%-26.66%+23.49% 111.67Cr
+4.11%-3.26%-51.23%-84.35% 93Cr
+5.56%+4.30%-14.86%-50.37% 68Cr
+0.58%-2.73%-39.57%-58.38% 55Cr
+3.24%-4.62%+35.87%-54.12% 44Cr
-1.26%-0.32%-54.06%-61.95% 38Cr
+3.15%+7.01%+20.57%+9.67% 33Cr
Average +0.86%-0.80%-12.26%-27.57% 219.83Cr
Weighted average by Cap. -1.07%-5.93%-3.27%-25.30%

Financials

2026 *2027 *
Net sales 77Cr 8.05Cr 7.02Cr 6.5Cr 6.09Cr 11Cr 760.02Cr 11Cr 30Cr 374.09Cr 30Cr 30Cr 1.3TCr 86Cr 9Cr 7.85Cr 7.27Cr 6.81Cr 13Cr 849.47Cr 13Cr 33Cr 418.12Cr 34Cr 33Cr 1.45TCr
Net income 14Cr 1.51Cr 1.32Cr 1.22Cr 1.14Cr 2.14Cr 142.75Cr 2.16Cr 5.62Cr 70Cr 5.68Cr 5.56Cr 243.98Cr 17Cr 1.82Cr 1.58Cr 1.47Cr 1.37Cr 2.58Cr 171.51Cr 2.59Cr 6.75Cr 84Cr 6.82Cr 6.68Cr 293.13Cr
Net Debt -22Cr -2.28Cr -1.99Cr -1.84Cr -1.72Cr -3.23Cr -214.94Cr -3.25Cr -8.46Cr -105.8Cr -8.55Cr -8.37Cr -367.35Cr -27Cr -2.78Cr -2.42Cr -2.24Cr -2.1Cr -3.94Cr -261.93Cr -3.96Cr -10Cr -128.93Cr -10Cr -10Cr -447.67Cr
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
241
Date Price Change Volume
18/26/18 136.80 kr -3.12% 55,672
17/26/17 141.20 kr -1.67% 70,172
16/26/16 143.60 kr -2.18% 1,38,201
15/26/15 146.80 kr +6.22% 2,97,418
12/26/12 138.20 kr +5.18% 61,122
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
136.80SEK
Average target price
179.00SEK
Spread / Average Target
+30.85%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CEVI Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!